Cardiovascular risk and body-fat abnormalities in HIV-infected adults

N Engl J Med. 2005 Jan 6;352(1):48-62. doi: 10.1056/NEJMra041811.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Anti-Retroviral Agents / adverse effects*
  • Anti-Retroviral Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Body Composition / drug effects
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV-Associated Lipodystrophy Syndrome / chemically induced
  • HIV-Associated Lipodystrophy Syndrome / therapy*
  • Humans
  • Hyperlipidemias / drug therapy
  • Hyperlipidemias / etiology*
  • Hypoglycemic Agents / therapeutic use
  • Hypolipidemic Agents / therapeutic use
  • Insulin Resistance*
  • Risk Assessment
  • Risk Factors

Substances

  • Anti-Retroviral Agents
  • Hypoglycemic Agents
  • Hypolipidemic Agents